| 期刊全稱 | Asymptomatic Atherosclerosis | | 期刊簡稱 | Pathophysiology, Det | | 影響因子2023 | Morteza Naghavi | | 視頻video | http://file.papertrans.cn/164/163767/163767.mp4 | | 發(fā)行地址 | Presents new multipronged strategies to aid in the early detection and treatment of asymptomatic atherosclerosis.Outlines more accurate measures of defining subclinical atherosclerosis, including coro | | 學(xué)科分類 | Contemporary Cardiology | | 圖書封面 |  | | 影響因子 | Despite recent advances in the diagnosis and treatment of symptomatic atherosclerosis, available traditional screening methods for early detection and treatment of asymptomatic coronary artery disease are grossly insufficient and fail to identify the majority of victims prior to the onset of a life-threatening event. In Asymptomatic Atherosclerosis: Pathophysiology, Detection and Treatment, Dr. Morteza Naghavi and leading authorities from the Society for Heart Attack Prevention and Eradication (SHAPE) present a new paradigm for the screening and primary prevention of asymptomatic atherosclerosis. The text focuses on accurate, yet underutilized, measures of subclinical atherosclerosis, notably coronary artery calcium scanning and carotid intima-media thickness measurement. The authors introduce a comprehensive approach to identifying the vulnerable patients (asymptomatic individuals at risk of a near future adverse event). Additional chapters discuss future directions towards containing the epidemic of atherosclerotic cardiovascular disease using innovative solutions such as preemptive interventional therapies (bioabsorbable stents) for stabilization of vulnerable atherosclerotic pl | | Pindex | Book 20111st edition |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-19 00:27
發(fā)表于 2025-3-21 16:09:26
